JP2001270820A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2001270820A JP2001270820A JP2000348909A JP2000348909A JP2001270820A JP 2001270820 A JP2001270820 A JP 2001270820A JP 2000348909 A JP2000348909 A JP 2000348909A JP 2000348909 A JP2000348909 A JP 2000348909A JP 2001270820 A JP2001270820 A JP 2001270820A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- skin
- bearberry
- oil
- reference example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000000284 extract Substances 0.000 claims abstract description 62
- 235000012871 Arctostaphylos uva ursi Nutrition 0.000 claims abstract description 38
- 241001071795 Gentiana Species 0.000 claims abstract description 28
- 229940069445 licorice extract Drugs 0.000 claims description 24
- 244000003892 Vaccinium erythrocarpum Species 0.000 claims 2
- 244000139693 Arctostaphylos uva ursi Species 0.000 abstract description 36
- 230000002087 whitening effect Effects 0.000 abstract description 11
- 206010014970 Ephelides Diseases 0.000 abstract description 7
- 208000003351 Melanosis Diseases 0.000 abstract description 7
- 206010042496 Sunburn Diseases 0.000 abstract description 7
- 241000202807 Glycyrrhiza Species 0.000 abstract description 4
- 240000003409 Gentiana lutea Species 0.000 abstract description 3
- 235000002873 Gentiana lutea Nutrition 0.000 abstract description 3
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 2
- 230000000481 effect on pigmentation Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 238000000605 extraction Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 208000012641 Pigmentation disease Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 230000019612 pigmentation Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- -1 packs Substances 0.000 description 5
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、クマコケモモ抽出
物、油溶性甘草抽出物及びゲンチアナ抽出物とを含有す
る皮膚外用剤に関し、更に詳細には、クマコケモモ抽出
物、油溶性甘草抽出物及びゲンチアナ抽出物との組合せ
により、色素沈着の発生を防止するなど皮膚に対する優
れた美白効果を有する皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to an external preparation for skin containing a bearberry extract, an oil-soluble licorice extract and a gentian extract, and more particularly to a bearberry berry extract, an oil-soluble licorice extract and a gentian extract. The present invention relates to an external preparation for skin having an excellent skin-whitening effect on the skin, such as by preventing pigmentation from occurring when combined with a product.
【0002】[0002]
【従来技術】従来より、乳液、クリーム、化粧水、パッ
ク、洗浄料、分散液、軟膏、外用液剤等の皮膚外用剤に
は、これらに所定の薬効を付与することを目的として薬
効成分が加えられている。例えば、日焼け等により生じ
る皮膚の黒化、色素沈着により生ずるシミ、ソバカス等
の現象を防止するために、アスコルビン酸やグルタチオ
ン、ハイドロキノン等の美白剤が加えられている。ま
た、クマコケモモの葉(ウワウルシ)の抽出物がシミ、
ソバカスなどの色素沈着を防ぎ美白効果を有することが
知られている(特開平6−166609号公報)。2. Description of the Related Art Conventionally, medicinal ingredients have been added to skin external preparations such as emulsions, creams, lotions, packs, detergents, dispersions, ointments, and external preparations for the purpose of imparting a predetermined medicinal effect to them. Have been. For example, whitening agents such as ascorbic acid, glutathione, and hydroquinone have been added to prevent phenomena such as darkening of the skin caused by sunburn, pigmentation, and spots and freckles caused by pigmentation. In addition, the extract of bearberry leaves (Uwaurushi) stains,
It is known that pigmentation such as freckles is prevented and has a whitening effect (JP-A-6-166609).
【0003】[0003]
【発明が解決しようとする課題】しかしながら、これら
の美白剤を含有した化粧品、外用医薬品等の皮膚外用剤
では、美白剤の効果が十分でなかったり、あるいは、製
剤中で変質するなどして所期の薬効が得られない場合が
あり、その改善が望まれていた。本発明は、安定且つ優
れた美白効果を有する皮膚外用剤を提供することを目的
とする。However, skin external preparations containing these whitening agents, such as cosmetics and external medicines, are not effective enough for the whitening agent or may be deteriorated in the preparation. In some cases, the medicinal effect of the first stage may not be obtained, and improvement has been desired. An object of the present invention is to provide a skin external preparation having a stable and excellent whitening effect.
【0004】[0004]
【課題を解決するための手段】本発明者らは、皮膚外用
剤の薬効成分の効果を向上させるべく鋭意検討を行った
結果、クマコケモモ抽出物、油溶性甘草抽出物及びゲン
チアナ抽出物を組み合わせれば、本来クマコケモモ抽出
物が有する美白作用を相乗的に高められることを見出
し、本発明を完成した。Means for Solving the Problems The present inventors have conducted intensive studies to improve the effect of the medicinal component of the external preparation for skin. As a result, the extract of the bearberry extract, the oil-soluble licorice extract and the gentian extract were combined. For example, the present inventors have found that the whitening effect of the bearberry extract can be enhanced synergistically, and completed the present invention.
【0005】すなわち、本発明は、次の成分(A)、
(B)及び(C) (A)クマコケモモ抽出物 (B)油溶性甘草抽出物 (C)ゲンチアナ抽出物 を含有することを特徴とする皮膚外用剤を提供するもの
である。That is, the present invention provides the following component (A):
(B) and (C) A skin external preparation characterized by containing (A) a bear berry extract (B) an oil-soluble licorice extract (C) a gentian extract.
【0006】[0006]
【発明の実施の形態】本発明の(A)成分であるクマコ
ケモモ抽出物は、ツツジ科に属する植物であって、クマ
コケモモ(学名Arctostaphylos uva ursi)の茎や葉
(ウワウルシ)から、抽出溶媒を用いて抽出する。その
調製法は特に限定されないが、例えば種々の適当な溶媒
を用いて低温もしくは室温〜加温下で抽出される。BEST MODE FOR CARRYING OUT THE INVENTION The Bearberry extract, which is the component (A) of the present invention, is a plant belonging to the family Azaleaaceae, and uses an extraction solvent from stems and leaves (Uwaurushi) of Bearberry (Arctostaphylos uva ursi). To extract. The preparation method is not particularly limited, but, for example, extraction is performed at low temperature or at room temperature to heating using various suitable solvents.
【0007】抽出溶媒としては、例えば水;メチルアル
コール、エチルアルコール等の低級1価アルコール;グ
リセリン、プロピレングリコール、1,3−ブチレング
リコール等の液状多価アルコール等の1種または2種以
上を用いることができる。好ましい抽出方法の例として
は、精製水を用い、加温しながら2〜3日間抽出を行っ
たのち、タンニン質の一部を取り除き、濾過し、得られ
た濾液をさらに5日間ほど放置して熟成させ、再び濾過
を行う方法が挙げられる。As the extraction solvent, for example, one or more of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol are used. be able to. As an example of a preferable extraction method, after performing extraction for 2 to 3 days while heating using purified water, a part of the tannin is removed, filtered, and the obtained filtrate is further left for about 5 days. A method of aging and filtering again.
【0008】本発明の(A)成分であるクマコケモモ抽
出物の含有量は、乾燥固形分として好ましくは0.00
01〜5質量%(以下単に「%」で示す)であり、より
好ましくは0.001〜3%である。クマコケモモ抽出
物の含有量がこの範囲であると、本発明の効果がより良
く発現する。The content of the bearberry extract, which is the component (A) of the present invention, is preferably 0.000 as a dry solid content.
01 to 5% by mass (hereinafter simply referred to as "%"), and more preferably 0.001 to 3%. When the content of the bearberry extract is within this range, the effects of the present invention are more effectively exhibited.
【0009】本発明の(B)である油溶性甘草抽出物
は、マメ科に属する多年草であって、甘草(学名Glycyr
rhiza glabra linne)から,抽出溶媒を用いて抽出する。
その調製法は特に限定されないが、例えば種々の適当な
溶媒を用いて低温もしくは室温〜加温下で抽出される。The oil-soluble licorice extract (B) of the present invention is a perennial herb belonging to the legume family, and is a licorice (scientific name: Glycyr).
rhiza glabra linne) using an extraction solvent.
The preparation method is not particularly limited, but, for example, extraction is performed at low temperature or at room temperature to heating using various suitable solvents.
【0010】抽出溶媒としては、例えばメチルアルコー
ル、エチルアルコール等の低級1価アルコール;グリセ
リン、プロピレングリコール、1,3−ブチレングリコ
ール等の液状多価アルコール等の1種または2種以上を
用いることができる。好ましい抽出方法の例としては、
エチルアルコールを用い、加温しながら2〜10時間抽
出を行ったのち濾過し、得られた濾液をさらに2〜3日
間ほど放置して熟成させ、再び濾過を行う方法が挙げら
れる。As the extraction solvent, one or more of lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol may be used. it can. Examples of preferred extraction methods include:
Extraction is performed for 2 to 10 hours using ethyl alcohol while heating, followed by filtration, and the obtained filtrate is left to mature for about 2 to 3 days, followed by filtration again.
【0011】本発明の(B)成分である油溶性甘草抽出
物の含有量は、乾燥固形分として好ましくは0.000
1〜5%であり、より好ましくは0.001〜3%であ
る。油溶性甘草抽出物の含有量がこの範囲であると、本
発明の効果がより良く発現する。The content of the oil-soluble licorice extract as the component (B) of the present invention is preferably 0.000 as a dry solid content.
1 to 5%, more preferably 0.001 to 3%. When the content of the oil-soluble licorice extract is within this range, the effects of the present invention are more effectively exhibited.
【0012】本発明の(C)成分であるゲンチアナ抽出
物は、リンドウ科に属する植物であって、ゲンチアナ
(学名Gentiana lutea linne(Gentianaceae))の根及び
根茎から、抽出溶媒を用いて抽出する。その調製法は特
に限定されないが、例えば種々の適当な溶媒を用いて低
温もしくは室温〜加温下で抽出される。The gentian extract, which is the component (C) of the present invention, is a plant belonging to the family Gentian and is extracted from roots and rhizomes of gentian (Gentiana lutea linne (Gentianaceae)) using an extraction solvent. The preparation method is not particularly limited, but, for example, extraction is performed at low temperature or at room temperature to heating using various suitable solvents.
【0013】抽出溶媒としては、例えば水;メチルアル
コール、エチルアルコール等の低級1価アルコール;グ
リセリン、プロピレングリコール、1,3−ブチレング
リコール等の液状多価アルコール等の1種または2種以
上を用いることができる。好ましい抽出方法の例として
は、50%1,3−ブチレングリコール水溶液を用い、
加温しながら2〜10時間抽出を行ったのち濾過し、得
られた濾液をさらに2〜3日間ほど放置して熟成させ、
再び濾過を行う方法が挙げられる。As the extraction solvent, for example, one or more of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol are used. be able to. As an example of a preferable extraction method, a 50% 1,3-butylene glycol aqueous solution is used,
After performing extraction for 2 to 10 hours while heating, filtration was performed, and the obtained filtrate was left to mature for about 2 to 3 days,
There is a method of performing filtration again.
【0014】本発明の(C)成分であるゲンチアナ抽出
物の含有量は、乾燥固形分として好ましくは0.000
1〜5%であり、より好ましくは0.001〜3%であ
る。ゲンチアナ抽出物の含有量がこの範囲であると、本
発明の効果がより良く発現する。The content of the gentian extract which is the component (C) of the present invention is preferably 0.000 as a dry solid content.
1 to 5%, more preferably 0.001 to 3%. When the content of the gentian extract is within this range, the effects of the present invention are better exhibited.
【0015】また、本発明の皮膚外用剤には、上記
(A)、(B)及び(C)成分以外に、必要に応じて本
発明の効果を損なわない範囲で、通常、化粧料や医薬部
外品、外用医薬品等の製剤に使用される成分、すなわ
ち、水(精製水、温泉水、深層水等)、油剤、界面活性
剤、金属セッケン、ゲル化剤、粉体、アルコール類、水
溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、包接化
合物、抗菌剤、香料、消臭剤、塩類、PH調整剤、清涼
剤、動物・微生物由来抽出物、植物抽出物、血行促進
剤、収斂剤、抗脂漏剤、活性酸素消去剤、細胞賦活剤、
保湿剤、角質溶解剤、酵素、ホルモン類、ビタミン類等
を加えることができる。In addition to the components (A), (B) and (C), the external preparation for skin of the present invention usually contains cosmetics and pharmaceuticals, if necessary, as long as the effects of the present invention are not impaired. Ingredients used in the preparation of quasi-drugs, topical medicines, etc., i.e., water (purified water, hot spring water, deep water, etc.), oils, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble Polymer, film forming agent, resin, ultraviolet ray protective agent, clathrate compound, antibacterial agent, fragrance, deodorant, salt, pH regulator, freshener, animal / microorganism-derived extract, plant extract, blood circulation promoter , Astringent, antiseborrheic, active oxygen scavenger, cell activator,
Moisturizers, keratolytic agents, enzymes, hormones, vitamins and the like can be added.
【0016】本発明の皮膚外用剤は、(A)成分、
(B)成分及び(C)成分を必須成分として配合し、常
法にしたがって調製できる。皮膚外用剤の形態の例とし
ては、特に限定されず、例えば、乳液、クリーム、化粧
水、パック、洗浄料等のスキンケア化粧料、口紅、ファ
ンデーション等のメーキャップ化粧料、軟膏、分散液、
外用液剤等の医薬品などとすることができ、その剤型に
ついても特に制限はなく、固型状、ペースト状、ムース
状、ジェル状、粉末状、溶液系、可溶化系、乳化系、粉
末分散系、多層状とすることができる。The external preparation for skin of the present invention comprises the component (A)
The components (B) and (C) are blended as essential components, and can be prepared according to a conventional method. Examples of the form of the external preparation for skin are not particularly limited and include, for example, emulsions, creams, lotions, packs, skin care cosmetics such as lipsticks, makeup cosmetics such as lipsticks, foundations, ointments, dispersions,
It can be a pharmaceutical such as a liquid for external use, etc., and there is no particular limitation on the form of the drug. Solid, paste, mousse, gel, powder, solution, solubilization, emulsification, powder dispersion The system can be in a multilayer form.
【0017】[0017]
【実施例】次に参考例、試験例及び実施例を挙げて本発
明を更に詳細に説明するが、本発明はこれらになんら制
約されるものではない。EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples and Examples, but the present invention is not limited thereto.
【0018】参考例1 クマコケモモ抽出物の製造 クマコケモモ(学名Arctostaphylos uva ursi)の葉を
乾燥したもの30gに、含水濃度80vol%エチルア
ルコール100mLを加え、室温にて3日間抽出を行っ
た後、濾過してクマコケモモ抽出物を得た(乾燥固形分
3.0%)。REFERENCE EXAMPLE 1 Production of Bearberry Extract (30 g) The dried leaves of Bearberry (Arctostaphylos uva ursi) were added to 30 g of dried leaves at a concentration of 80 vol% ethyl alcohol (100 mL), extracted at room temperature for 3 days, and filtered. Thus, a bearberry extract was obtained (dry solid content: 3.0%).
【0019】参考例2 クマコケモモ抽出物の製造 クマコケモモ(学名Arctostaphylos uva ursi)の葉を
乾燥したもの30gに、含水濃度80vol%1,3−
ブチレングリコール100mLを加え、室温にて3日間
抽出を行った後、濾過してクマコケモモ抽出物を得た
(乾燥固形分2.50%)。Reference Example 2 Production of Bearberry extract (30 g of dried leaves of Bearberry) (scientific name: Arctostaphylos uva ursi) was added to 30 g of dried leaf containing 80 vol% of 1,3-
After adding 100 mL of butylene glycol, extraction was performed at room temperature for 3 days, and filtration was performed to obtain a bearberry extract (2.50% dry solid content).
【0020】参考例3 油溶性甘草抽出物の製造 甘草(学名Glycyrrhiza glabra linne)の根を乾燥した
もの20gに、エチルアルコール100mLを加え、室
温にて5日間抽出を行った後、濾過して油溶性甘草エキ
スを得た(乾燥固形分:5.0%)。Reference Example 3 Production of oil-soluble licorice extract To 20 g of dried licorice (Glycyrrhiza glabra linne) root, 100 mL of ethyl alcohol was added, and the mixture was extracted at room temperature for 5 days. A soluble licorice extract was obtained (dry solid content: 5.0%).
【0021】参考例4 ゲンチアナ抽出物 ゲンチアナ(学名Gentiana lutea linne(Gentianacea
e))の根及び根茎の粗末10gにそれぞれ20vol%
エチルアルコール100mLを加え、室温で時々撹拌し
ながら3日間抽出を行った後、濾過してゲンチアナ抽出
物を得た(乾燥固形分はそれぞれ3.0%)。Reference Example 4 Gentian extract Gentian (scientific name: Gentiana lutea linne (Gentianacea
e)) 20 vol% to 10 g of coarse powder of root and rhizome
100 mL of ethyl alcohol was added, and the mixture was extracted for 3 days with occasional stirring at room temperature, followed by filtration to obtain a gentian extract (dry solid content: 3.0% each).
【0022】試験例1 チロシナーゼ活性阻害試験 下記方法により、参考例1で得たクマコケモモ抽出物、
参考例2で得た油溶性甘草抽出物及び参考例3で得たゲ
ンチアナ抽出物について、単独またはそれらを組み合わ
せた試料のチロシナーゼ活性阻害率を調べた。すなわ
ち、各試料に酵素溶液[シグマ社製、28,000単位
のチロシナーゼ10mgを0.1mol/Lリン酸緩衝
液(pH6.8)20mLに溶解したもの]0.1mL
を加え、さらに0.1Mリン酸緩衝液(pH6.8)を
加え4.0mLとし、これを25℃にて10分間インキ
ュベートした。Test Example 1 Tyrosinase activity inhibition test The bearberry extract obtained in Reference Example 1 was obtained by the following method.
Regarding the oil-soluble licorice extract obtained in Reference Example 2 and the gentian extract obtained in Reference Example 3, the tyrosinase activity inhibition rate of a sample alone or in combination thereof was examined. That is, 0.1 mL of an enzyme solution [10 mg of tyrosinase (28,000 units, manufactured by Sigma) dissolved in 20 mL of 0.1 mol / L phosphate buffer (pH 6.8)] was added to each sample.
Was added, and 0.1 M phosphate buffer (pH 6.8) was further added to make 4.0 mL, which was incubated at 25 ° C. for 10 minutes.
【0023】次いで、これにあらかじめ25℃に保って
おいた基質溶液[L−DOPA(東京化成社製)19
8.0mgを0.1mol/Lリン酸緩衝液(pH6.
8)100mLに溶解したもの]1.0mLを加え、1
0分間反応せしめた。反応後、475nmにおける吸光
度(ODS)を測定した。同様に、加熱失活させた前記
酵素を用いて反応させた時の吸光度(ODHE)、酵素を
添加し試料を添加しない時の吸光度(ODB)及び試料
と不活性化した酵素を添加した時の吸光度(ODS HE)
を測定し、数式1よりチロシナーゼ活性の活性阻害率を
算出し、この結果を表1に示す。Next, a substrate solution [L-DOPA (manufactured by Tokyo Chemical Industry Co., Ltd.) 19
8.0 mg of 0.1 mol / L phosphate buffer (pH 6.0)
8) Dissolved in 100 mL] and added 1.0 mL
It was allowed to react for 0 minutes. After the reaction, the absorbance at 475 nm (OD S ) was measured. Similarly, the absorbance (OD HE ) when the enzyme was reacted with the heat-inactivated enzyme, the absorbance (OD B ) when the enzyme was added and the sample was not added, and the sample and the inactivated enzyme were added. Absorbance (OD S HE )
Was measured, and the activity inhibition rate of tyrosinase activity was calculated from Formula 1 and the results are shown in Table 1.
【0024】[0024]
【数1】 (Equation 1)
【0025】式中、ODSは試料及び酵素添加時の吸光
度、ODBは酵素を添加し試料を添加しない時の吸光
度、ODHEは酵素不活性時の吸光度、ODSHEは試料と
不活性化した酵素を添加した時の吸光度である。[0025] In the formula, OD S absorbance upon addition Samples and enzymes, OD B is the absorbance in the case without addition of the sample enzyme addition, OD HE absorbance at enzyme inactivation, OD SHE samples and inactivation This is the absorbance when the added enzyme is added.
【0026】[0026]
【表1】 [Table 1]
【0027】表1から明らかなごとく、クマコケモモ抽
出物、油溶性甘草抽出物及びゲンチアナ抽出物を組み合
わせた場合には、クマコケモモ抽出物、油溶性甘草抽出
物又はゲンチアナ抽出物をそれぞれ単独で用いた場合よ
りもかなり高いチロシナーゼ活性阻害効果を示した。As is evident from Table 1, when the bearberry extract, oil-soluble licorice extract and gentian extract are combined, when the bearberry extract, oil-soluble licorice extract and gentian extract are used alone, respectively. Tyrosinase activity was significantly higher than that of tyrosinase.
【0028】試験例2 細胞培養によるメラニン生成抑
制試験 下記方法により、参考例1で得たクマコケモモ抽出物、
参考例2で得た油溶性甘草抽出物及び参考例3で得たゲ
ンチアナ抽出物について、単独またはそれらを組み合わ
せた試料のメラニン生成抑制作用を調べた。培養細胞に
は、マウス由来のB16メラノーマ培養細胞を用いて、
2枚の6穴シャーレに培地を適量とり、B16メラノー
マ細胞を播種し、37℃、二酸化炭素濃度5%中にて静
置した。翌日、各試料を最終濃度が0(対照)、1、1
0、100μg/mLとなるように検体調製液を添加し
混和した。培養5日目に培地を交換し、再度検体調製液
を添加した。翌日、培地を除き、1枚のシャーレについ
て、細胞をリン酸緩衝液にて洗浄した後回収し、B16
メラノーマ培養細胞の白色化度を以下の基準にて評価し
た。Test Example 2 Melanin Production Inhibition Test by Cell Culture The bearberry extract obtained in Reference Example 1 was obtained by the following method.
With respect to the oil-soluble licorice extract obtained in Reference Example 2 and the gentian extract obtained in Reference Example 3, a melanin production inhibitory effect of a sample alone or in combination thereof was examined. For cultured cells, mouse-derived B16 melanoma cultured cells were used.
An appropriate amount of the medium was taken in two 6-well dishes, and B16 melanoma cells were inoculated and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%. On the next day, each sample was tested at a final concentration of 0 (control), 1, 1
A sample preparation solution was added and mixed so as to be 0 and 100 μg / mL. On the fifth day of the culture, the medium was replaced, and the sample preparation solution was added again. On the next day, the medium was removed, and the cells were washed with a phosphate buffer in one petri dish and collected.
The whitening degree of the melanoma cultured cells was evaluated based on the following criteria.
【0029】(判定基準) ++:対照に対して極めて白色である。 + :対照に対してあきらかに白色である。 ± :対照に対してやや白色である。 − :対照と同じ黒色である。(Criterion) ++: extremely white with respect to the control. +: Clearly white with respect to the control. ±: slightly white with respect to the control. -: The same black color as the control.
【0030】残りの1枚のシャーレについて、細胞をホ
ルマリン固定後、1%クリスタルバイオレット溶液に添
加し染色した。各検体濃度に対する生存細胞率をモノセ
レーター(オリンパス社製)で測定した。以上の結果を
表2に示す。For the remaining one petri dish, the cells were fixed in formalin and added to a 1% crystal violet solution for staining. The viable cell ratio for each sample concentration was measured with a monocerator (Olympus). Table 2 shows the above results.
【0031】[0031]
【表2】 [Table 2]
【0032】表2から明らかなごとく、クマコケモモ抽
出物、油溶性甘草抽出物及びゲンチアナ抽出物を組み合
わせた場合には、クマコケモモ抽出物、油溶性甘草抽出
物又はゲンチアナ抽出物をそれぞれ単独で用いた場合よ
りもかなり高い美白作用を示し、かつB16メラノーマ
培養細胞に対し毒性が低いことが認められた。As is evident from Table 2, when the bearberry extract, the oil-soluble licorice extract and the gentian extract are combined, when the bearberry extract, the oil-soluble licorice extract and the gentian extract are used alone, respectively. It showed a much higher whitening effect than the above, and was found to be less toxic to cultured B16 melanoma cells.
【0033】試験例3 色素沈着抑制試験 有色モルモット(各群15匹)の背部を剃毛し、麻酔下
紫外線を照射した。紫外線照射は、東芝(株)製FL2
0S・BLBランプとFL20S・E30ランプを3本
ずつ同時に照射し、紫外線量は4.8×106erg/
cm2とした。紫外線照射24時間前と照射直後及び照
射12時間後、24時間後にモルモット背部の4ヶ所
に、表3に示した組成及び下記製法で調製した試料を
0.2gずつ塗布した。但し、照射前には塗布部位を温
水でよく洗浄した。照射7日後に色素沈着の程度を観察
し、以下に示す規準で評価した。この結果を表3に示
す。Test Example 3 Pigmentation Inhibition Test The back of a colored guinea pig (15 animals in each group) was shaved and irradiated with ultraviolet light under anesthesia. UV irradiation is performed by FL2 manufactured by Toshiba Corporation.
Irradiate three 0S • BLB lamps and three FL20S • E30 lamps at the same time, and the amount of ultraviolet rays is 4.8 × 10 6 erg /
cm 2 . Twenty-four hours before, immediately after, and 12 hours after and 24 hours after the irradiation with ultraviolet rays, 0.2 g each of the composition shown in Table 3 and the sample prepared by the following method were applied to four places on the back of the guinea pig. However, before irradiation, the application site was thoroughly washed with warm water. Seven days after irradiation, the degree of pigmentation was observed and evaluated according to the following criteria. Table 3 shows the results.
【0034】[0034]
【表3】 [Table 3]
【0035】(製法)A.成分(1)〜(6)、(1
0)を混合し、加熱して70℃に保つ。 B.(12)を加熱して70℃に保つ。 C.AにBを加え、混合した後、冷却して(7)、
(8)、(9)及び(11) を加えて混合し、クリームを得た。(Production method) Components (1) to (6), (1
0) is mixed and heated to 70 ° C. B. Heat (12) and keep at 70 ° C. C. Add B to A, mix and cool (7)
(8), (9) and (11) were added and mixed to obtain a cream.
【0036】 (色素沈着抑制効果の評価規準) <評価> <内 容> 著 効 色素沈着が全く認められない。 有 効 色素沈着がごく僅かに認められる。 やや有効 色素沈着が認められるが、非照射部位との境界が不明瞭。 無 効 色素沈着が認められ、非照射部位との境界が鮮明。(Evaluation Criteria for Pigmentation Inhibition Effect) <Evaluation> <Contents> Excellent Effect No pigmentation was observed at all. Effective Very slight pigmentation is observed. Slightly effective pigmentation is observed, but the boundary with the non-irradiated part is unclear. Ineffective Pigmentation was observed, and the boundary with the non-irradiated part was clear.
【0037】表3の結果(色素沈着抑制効果の欄の数字
は、それぞれに該当したモルモットの匹数である)に示
される如く、クマコケモモ抽出物、油溶性甘草抽出物及
びゲンチアナ抽出物を組合せた本発明品1の皮膚外用剤
は、これらを皮膚に適用することにより、紫外線による
色素沈着を効果的に抑制することが明らかとなった。As shown in the results in Table 3 (the numbers in the column of the effect of inhibiting pigmentation are the number of guinea pigs corresponding to each), the bearberry extract, the oil-soluble licorice extract and the gentian extract were combined. It has been clarified that the skin external preparation of the present invention product 1 effectively suppresses pigmentation due to ultraviolet rays by applying them to the skin.
【0038】 実施例1 化粧水 (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレン(20E.O.) 1.2 ソルビタンモノラウリン酸エステル (4)エチルアルコール 8.0 (5)クマコケモモ抽出物*1 0.5 (6)油溶性甘草抽出物*2 0.1 (7)ゲンチアナ抽出物*3 0.2 (8)防腐剤 適量 (9)香料 適量 (10)精製水 残量 *1 参考例1で製造したもの *2 参考例3で製造したもの *3 参考例4で製造したものExample 1 Lotion (Formulation) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene (20EO) 1.2 Sorbitan monolaurin Acid ester (4) Ethyl alcohol 8.0 (5) Bearberry extract * 1 0.5 (6) Oil-soluble licorice extract * 2 0.1 (7) Gentian extract * 3 0.2 (8) Preservative Appropriate amount (9) Perfume Appropriate amount (10) Remaining purified water * 1 Produced in Reference Example 1 * 2 Produced in Reference Example 3 * 3 Produced in Reference Example 4
【0039】(製法) A.成分(3)、(4)、(8)及び(9)を混合溶解
する。 B.成分(1)、(2)、(5)、(6)、(7)及び
(10)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。(Production method) Components (3), (4), (8) and (9) are mixed and dissolved. B. Components (1), (2), (5), (6), (7) and (10) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0040】 実施例2 乳液 (処方) (%) (1)ポリオキシエチレン(10E.O.) 1.0 ソルビタンモノステアレート (2)ポリオキシエチレン(60E.O.) 0.5 ソルビットテトラオレエート (3)グリセリルモノステアレート 1.0 (4)ステアリン酸 0.5 (5)ベヘニルアルコール 0.5 (6)スクワラン 8.0 (7)クマコケモモ抽出物*1 0.3 (8)油溶性甘草抽出物*2 0.1 (9)ゲンチアナ抽出物*3 0.3 (10)防腐剤 0.1 (11)カルボキシビニルポリマー 0.1 (12)水酸化ナトリウム 0.05 (13)1,3−ブチレングリコール 5.0 (14)精製水 残量 (15)香料 適量 *1 参考例1で製造したもの *2 参考例3で製造したもの *3 参考例4で製造したものExample 2 Emulsion (Formulation) (%) (1) Polyoxyethylene (10EO) 1.0 Sorbitan monostearate (2) Polyoxyethylene (60EO) 0.5 Sorbit tetraole Eate (3) Glyceryl monostearate 1.0 (4) Stearic acid 0.5 (5) Behenyl alcohol 0.5 (6) Squalane 8.0 (7) Bearberry extract * 1 0.3 (8) Oil-soluble licorice Extract * 2 0.1 (9) Gentian extract * 3 0.3 (10) Preservative 0.1 (11) Carboxyvinyl polymer 0.1 (12) Sodium hydroxide 0.05 (13) 1,3 -Butylene glycol 5.0 (14) Remaining amount of purified water (15) Appropriate amount of fragrance * 1 Manufactured in Reference Example 1 * 2 Manufactured in Reference Example 3 * 3 Manufactured in Reference Example
【0041】(製法) A.成分(12)及び(13)を(14)の一部に加熱
混合し、70℃に保つ。 B.成分(1)〜(6)及び(10)を加熱混合し、7
0℃に保つ。 C.BにAを加えて混合し、均一に乳化する。 D.Cを冷却後(7)〜(9)、(11)を(14)の
残部に混合溶解し、(15)を加え、均一に混合して乳
液を得た。(Production method) Heat and mix components (12) and (13) with a portion of (14) and maintain at 70 ° C. B. Components (1) to (6) and (10) are mixed by heating.
Keep at 0 ° C. C. Add A to B, mix and emulsify uniformly. D. After cooling C, (7) to (9) and (11) were mixed and dissolved in the remainder of (14), (15) was added, and the mixture was uniformly mixed to obtain an emulsion.
【0042】実施例1及び実施例2はいずれも経時安定
性に優れ、皮膚に適用することにより、日焼けによる肌
の「くすみ」やシミやソバカスを防止し、透明感のある
美しい肌にする化粧水及び乳液であった。Each of Examples 1 and 2 has excellent stability over time, and when applied to the skin, prevents "dullness" of the skin due to sunburn, spots and freckles, and makes the skin beautiful and transparent. Water and emulsion.
【0043】 実施例3 軟膏 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)トリエタノールアミン 2.0 (4)グリセリン 5.0 (5)クマコケモモ抽出物*1 0.2 (6)油溶性甘草抽出物*2 0.1 (7)ゲンチアナ抽出物*3 0.3 (8)精製水 残量 *1 参考例2で製造したもの *2 参考例3で製造したもの *3 参考例4で製造したものExample 3 Ointment (Formulation) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Bearberry extract * 1 0.2 (6) Oil-soluble licorice extract * 2 0.1 (7) Gentian extract * 3 0.3 (8) Remaining amount of purified water * 1 Produced in Reference Example 2 * 2 Reference Example 3 * 3 Manufactured in Reference Example 4
【0044】(製法) A.成分(3)、(4)及び(8)を加熱混合し、75
℃に保つ。 B.成分(1)及び(2)を加熱混合し、75℃に保
つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(5)、(6)、(7)を加え、
軟膏を得た。(Production Method) A. Heat-mix components (3), (4) and (8) and mix
Keep at ° C. B. Heat mix components (1) and (2) and maintain at 75 ° C. C. Add A slowly to B. D. While cooling C, add (5), (6) and (7)
An ointment was obtained.
【0045】実施例3は経時安定性に優れ、皮膚に適用
することにより、肌の「くすみ」やシミやソバカスを防
止し、透明感のある美しい肌にする軟膏であった。Example 3 was an ointment which was excellent in stability over time and applied to the skin to prevent "dullness", spots and freckles on the skin, and to give a clear and beautiful skin.
【0046】 実施例4 パック (処方) (%) (1)ポリビニルアルコール 20.0 (2)エチルアルコール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)クマコケモモ抽出物*1 0.1 (6)油溶性甘草抽出物*2 0.1 (7)ゲンチアナ抽出物*3 0.2 (8)防腐剤 0.2 (9)香料 0.1 (10)精製水 残量 *1 参考例2で製造したもの *2 参考例3で製造したもの *3 参考例4で製造したものExample 4 Pack (Formulation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethyl alcohol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Bearberry extract * 1 0.1 (6) Oil-soluble licorice extract * 2 0.1 (7) Gentian extract * 3 0.2 (8) Preservative 0.2 (9) Fragrance 0.1 (10) Purified water * 1 Manufactured in Reference Example 2 * 2 Manufactured in Reference Example 3 * 3 Manufactured in Reference Example 4
【0047】(製法) A.成分(1)〜(4)、(8)及び(10)を混合
し、70℃に加熱し、撹拌する。B.Aを冷却した後、
(5)〜(7)及び(9)を添加し均一に撹拌してパッ
クを得た。(Production method) Mix components (1)-(4), (8) and (10), heat to 70 ° C. and stir. B. After cooling A,
(5) to (7) and (9) were added and stirred uniformly to obtain a pack.
【0048】実施例4は経時安定性に優れ、皮膚に適用
することにより、肌の「くすみ」やシミを防止し、透明
感のある美しい肌にするパックであった。Example 4 was a pack which was excellent in stability over time and applied to the skin to prevent the skin from dulling and spotting, and to make the skin transparent and beautiful.
【0049】 実施例5 リキッドファンデーション (処方) (%) (1)ラノリン 7.0 (2)流動パラフィン 5.0 (3)ステアリン酸 2.0 (4)セタノール 1.0 (5)パラメトキシケイ皮酸 3.0 −2−エチルヘキシル (6)4−t−ブチル−4’−メトキシ 1.0 ジベンゾイルメタン (7)グリセリン 5.0 (8)トリエタノールアミン 1.0 (9)カルボキシメチルセルロース 0.7 (10)精製水 残量 (11)マイカ 15.0 (12)タルク 6.0 (13)着色顔料 6.0 (14)クマコケモモ抽出物*1 0.1 (15)油溶性甘草抽出物*2 0.1 (16)ゲンチアナ抽出物*3 0.2 (17)香料 適量 *1 参考例1で製造したもの *2 参考例3で製造したもの *3 参考例4で製造したものExample 5 Liquid Foundation (Formulation) (%) (1) Lanolin 7.0 (2) Liquid Paraffin 5.0 (3) Stearic Acid 2.0 (4) Cetanol 1.0 (5) Paramethoxy Silicate Cinnamic acid 3.0-2-ethylhexyl (6) 4-t-butyl-4'-methoxy 1.0 dibenzoylmethane (7) glycerin 5.0 (8) triethanolamine 1.0 (9) carboxymethylcellulose 0 0.7 (10) Remaining purified water (11) Mica 15.0 (12) Talc 6.0 (13) Color pigment 6.0 (14) Bearberry extract * 1 0.1 (15) Oil-soluble licorice extract * 2 0.1 (16) Gentian extract * 3 0.2 (17) Perfume appropriate amount * 1 Manufactured in Reference Example 1 * 2 Manufactured in Reference Example 3 * 3 Manufactured in Reference Example 4
【0050】(製法) A.成分(1)〜(6)を混合溶解する。 B.Aに成分(11)〜(13)を加え、均一に混合
し、70℃に保つ。 C.成分(7)〜(10)を均一に溶解し、70℃に保
つ。 D.BにCを添加して、均一に乳化する。 E.Dを冷却後、成分(14)〜(17)を添加してリ
キッドファンデーションを得た。(Production method) Components (1) to (6) are mixed and dissolved. B. Add components (11) to (13) to A, mix uniformly, and keep at 70 ° C. C. Components (7) to (10) are uniformly dissolved and kept at 70 ° C. D. Add C to B and emulsify uniformly. E. FIG. After cooling D, components (14) to (17) were added to obtain a liquid foundation.
【0051】実施例5は経時安定性に優れ、皮膚に適用
することにより、日焼け等による肌の黒化やシミやソバ
カスを防止するリキッドファンデーションであった。Example 5 was a liquid foundation which was excellent in stability over time and applied to the skin to prevent darkening of the skin due to sunburn, spots and freckles.
【0052】[0052]
【発明の効果】本発明によれば、クマコケモモ抽出物、
油溶性甘草抽出物及びゲンチアナ抽出物を含有すること
により、本来クマコケモモ抽出物が有する美白作用を相
乗的に高めることができる。すなわち、安定で且つ優れ
た美白作用を有するため、日焼けによる色素沈着に高い
抑制効果を発揮し、日焼けなどによる皮膚の黒化、シ
ミ、ソバカスの防止・改善等に有効である。このよう
に、本発明の皮膚外用剤は、美白剤の本来有する性能を
十分に発揮させることができるため、美容や医療におい
て極めて有用なものである。According to the present invention, bearberry extract,
By containing the oil-soluble licorice extract and the gentian extract, the whitening effect originally possessed by the bearberry extract can be synergistically enhanced. That is, since it has a stable and excellent whitening effect, it exerts a high inhibitory effect on pigmentation due to sunburn, and is effective in preventing / improving skin blackening, spots and freckles due to sunburn. As described above, the skin external preparation of the present invention can sufficiently exhibit the inherent performance of a whitening agent, and is therefore extremely useful in beauty and medicine.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 畑 友紀 東京都北区栄町48番18号 株式会社コーセ ー研究本部内 (72)発明者 中山 宏基 東京都新宿区西新宿八丁目5番10号 ペン タファーム ジャパン株式会社内 Fターム(参考) 4C083 AA082 AA111 AA112 AB032 AB432 AB442 AC022 AC072 AC102 AC122 AC242 AC342 AC422 AC442 AC542 AD092 AD112 AD512 BB41 CC02 CC03 CC04 CC05 CC07 EE16 4C088 AB44 AB59 AB67 AC05 BA10 MA07 MA28 NA05 ZA89 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Yuki Hata 48-18, Sakaemachi, Kita-ku, Tokyo Inside Kose Research Laboratory (72) Inventor Hiroki Nakayama 8-5-1 Nishishinjuku, Shinjuku-ku, Tokyo T-farm Japan Co., Ltd.
Claims (4)
1〜5質量%である請求項1記載の皮膚外用剤。2. The content of the bearberry extract is 0.000.
The external preparation for skin according to claim 1, which is 1 to 5% by mass.
〜5質量%である請求項1記載の皮膚外用剤。3. The oil-soluble licorice extract content of 0.0001.
The external preparation for skin according to claim 1, wherein the amount is from 5 to 5% by mass.
〜5質量%である請求項1記載の皮膚外用剤。4. A gentian extract having a content of 0.0001.
The external preparation for skin according to claim 1, wherein the amount is from 5 to 5% by mass.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000348909A JP2001270820A (en) | 2000-01-20 | 2000-11-16 | Skin care preparation |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-11215 | 2000-01-20 | ||
| JP2000011215 | 2000-01-20 | ||
| JP2000348909A JP2001270820A (en) | 2000-01-20 | 2000-11-16 | Skin care preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001270820A true JP2001270820A (en) | 2001-10-02 |
Family
ID=26583821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000348909A Pending JP2001270820A (en) | 2000-01-20 | 2000-11-16 | Skin care preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001270820A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
| DE102012211030A1 (en) | 2012-06-27 | 2014-01-02 | Beiersdorf Ag | Use of creatine for lightening cosmetic preparation comprising active ingredients with natural color |
-
2000
- 2000-11-16 JP JP2000348909A patent/JP2001270820A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
| DE102012211030A1 (en) | 2012-06-27 | 2014-01-02 | Beiersdorf Ag | Use of creatine for lightening cosmetic preparation comprising active ingredients with natural color |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3638832B2 (en) | Cosmetic and / or dermatological composition comprising at least one mulberry extract, at least one seaweed extract and at least one salicylic acid derivative | |
| JP2000095663A (en) | Agent for external use containing plant extract | |
| JPH0812565A (en) | Skin external preparation | |
| JPH06128143A (en) | External agent for skin | |
| JPH0812560A (en) | Skin external preparation | |
| JP3480954B2 (en) | External preparation for skin | |
| JP2003183175A (en) | alpha-MSH INHIBITOR ORIGINATING FROM TEA EXTRACT AND WHITENING AGENT, ANTI-AGING AGENT AND MMP-1 PRODUCTION INHIBITOR CONTAINING THE SAME, AND SKIN CARE PREPARATION CONTAINING THESE | |
| JPH0812561A (en) | Beautifying and whitening skin preparation for external use | |
| JPH0925209A (en) | Skin preparation for external use | |
| JPH09241154A (en) | Preparation for external use for skin | |
| JP2001181170A (en) | Skin care preparation | |
| JP2001270820A (en) | Skin care preparation | |
| JP2002145752A (en) | Skin external preparation and skin external composition | |
| JP2003026532A (en) | Skin care preparation | |
| JPH0971522A (en) | Skin preparation for external use for lightening skin | |
| JP3527406B2 (en) | Skin whitening external preparation | |
| JPH08301758A (en) | Skin preparation for external use | |
| JPH0812552A (en) | Skin external preparation | |
| JPH0987135A (en) | Dermal preparation for external use | |
| JPH11246344A (en) | Preparation for external use for skin bleaching | |
| JPH0920635A (en) | Whitening skin preparation for external use | |
| JP3388950B2 (en) | External preparation for skin | |
| JPH0812550A (en) | Skin external preparation | |
| JPH0812557A (en) | Skin external preparation | |
| JPH11246343A (en) | Preparation for external use for skin bleaching |